Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
Recent advances in cancer immunotherapy have steadily increased the effectiveness of standard antitumor therapy methods. Due to their low toxicity and simple production process, personalized therapeutic vaccines based on dendritic cells are of particular clinical interest. A striking fact is that th...
Saved in:
Main Authors: | I.Yu. Filin, K.V. Kitaeva, A.A. Rizvanov, V.V. Solovyeva |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazan Federal University
2022-09-01
|
Series: | Учёные записки Казанского университета: Серия Естественные науки |
Subjects: | |
Online Access: | https://kpfu.ru/uz-eng-ns-2022-3-1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Antigen presentation in cancer immune responses
by: Marie-Liesse Asselin-Labat, et al.
Published: (2025-01-01) -
New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells
by: Zélia Silva, et al.
Published: (2024-11-01) -
HIFU-CCL19/21 Axis Enhances Dendritic Cell Vaccine Efficacy in the Tumor Microenvironment
by: Bum-Seo Baek, et al.
Published: (2025-01-01) -
Molecular Mechanism of VSV-Vectored ASFV Vaccine Activating Immune Response in DCs
by: Yunyun Ma, et al.
Published: (2025-01-01) -
A novel tissue culture method to produce professional antigen-presenting cells from rainbow trout in vitro
by: Nguyen T. K. Vo, PhD, et al.
Published: (2025-06-01)